1. Home
  2. LASR vs WVE Comparison

LASR vs WVE Comparison

Compare LASR & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • WVE
  • Stock Information
  • Founded
  • LASR 2000
  • WVE 2012
  • Country
  • LASR United States
  • WVE Singapore
  • Employees
  • LASR N/A
  • WVE N/A
  • Industry
  • LASR Semiconductors
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • WVE Health Care
  • Exchange
  • LASR Nasdaq
  • WVE Nasdaq
  • Market Cap
  • LASR 903.8M
  • WVE 915.6M
  • IPO Year
  • LASR 2018
  • WVE 2015
  • Fundamental
  • Price
  • LASR $31.77
  • WVE $8.43
  • Analyst Decision
  • LASR Strong Buy
  • WVE Strong Buy
  • Analyst Count
  • LASR 6
  • WVE 14
  • Target Price
  • LASR $27.42
  • WVE $20.79
  • AVG Volume (30 Days)
  • LASR 676.4K
  • WVE 3.1M
  • Earning Date
  • LASR 11-06-2025
  • WVE 11-07-2025
  • Dividend Yield
  • LASR N/A
  • WVE N/A
  • EPS Growth
  • LASR N/A
  • WVE N/A
  • EPS
  • LASR N/A
  • WVE N/A
  • Revenue
  • LASR $216,913,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • LASR $23.44
  • WVE N/A
  • Revenue Next Year
  • LASR $8.73
  • WVE $6.26
  • P/E Ratio
  • LASR N/A
  • WVE N/A
  • Revenue Growth
  • LASR 9.79
  • WVE N/A
  • 52 Week Low
  • LASR $6.20
  • WVE $5.28
  • 52 Week High
  • LASR $33.96
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • LASR 53.52
  • WVE 61.92
  • Support Level
  • LASR $29.49
  • WVE $7.34
  • Resistance Level
  • LASR $33.91
  • WVE $9.75
  • Average True Range (ATR)
  • LASR 1.52
  • WVE 0.56
  • MACD
  • LASR -0.02
  • WVE 0.10
  • Stochastic Oscillator
  • LASR 55.42
  • WVE 53.19

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: